Ocrevus Outperforms Rebif in Preventing Myelin Loss & When to Tell Others About MS

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how two years of Ocrevus treatment outperformed Rebif at preventing myelin loss in people with relapsing forms of multiple sclerosis.He also reads “Dreams, Diagnoses, and Disclosures: When to Tell Others About MS” by Ed Tobias, from his column “The MS Wire”.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/